Table 2.
Genetic defect | Syndrome | Clinical manifestations | Parathyroid pathology |
---|---|---|---|
GCM2 (6p23-24) SOX3 (insertion-deletion 2p25.3 and Xq26-27) |
Isolated parathyroid aplasia |
Primary hypoparathyroidism Infantile hypocalcemic seizures |
Agenesis of parathyroid glands |
TBX1(22q11.2) NEBL (10p13) |
DiGeorge Syndrome (DGS, type 1) DGS, type 2 |
Thymic aplasia, T-cell defects, conotruncal anomalies, cleft palate, dysmorphic facies | Hypoalcemia due to parathyroid hypoplasia |
CHD7 (8q12.2) SEMA3E (7q21.11) |
CHARGE syndrome | Coloboma, heart defects, choanal atresia, retarded growth, genital hypoplasia, ear anomalies | Hypocalcemia due to parathyroid hypoplasia |
GATA3 haploinsufficiency | HDR/Barakat syndrome | Transient to severe neonatal hypocalcemia, deafness, renal dysplasia | Hypocalcemia due to parathyroid hypoplasia |
TBCE (1q42-43) |
HRD/Sanjad-Sakati Syndrome (Arabic descent mostly) KCS/Kenny-Caffey syndrome |
Hypoparathyroidism, retardation, dysmorphism | Hypocalcemia due to parathyroid hypoplasia |
Mitochondrial disease (Kearns-Sayre, Pearson Marrow-pancreas syndromes, MELAS, LCHAD, MCADD) | Various manifestations based on the specific disease | Hypoparathyroidism | |
PTH (11p15.3-p15.1) | Isolated familial hypoparathyroidism | Hypocalcemia | Hypocalcemia due to defective PTH |
CASR (ADH1) (3q13.3-q21.1) GNA11 (ADH2) (19p13) |
Autosomal dominant hypocalcemia, types 1 and 2 | Neonatal to adult presentation of hypocalcemia (increased urinary calcium excretion, decreased PTH synthesis) | Increased sensitivity of the calcium sensing receptor to extracellular ionized calcium |
AIRE (21q22.3) | Autoimmune polyendrocrinopathy candidiasis ectodermal dysplasia (APECED) | Mucocutaneous candidiasis, hypoparathyroidism, adrenal insufficiency, endocrinopathies, hepatitis, vitiligo, alopecia, nail/dental dystrophy | Hypocalcemia due to autoimmune destruction of parathyroid glands |